Takotsubo Syndrome: Translational Implications and Pathomechanisms

Takotsubo syndrome (TTS) is identified as an acute severe ventricular systolic dysfunction, which is usually characterized by reversible and transient akinesia of walls of the ventricle in the absence of a significant obstructive coronary artery disease (CAD). Patients present with chest pain, ST-se...

Full description

Bibliographic Details
Main Authors: Xuehui Fan, Guoqiang Yang, Jacqueline Kowitz, Ibrahim Akin, Xiaobo Zhou, Ibrahim El-Battrawy
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/4/1951
_version_ 1797479486992678912
author Xuehui Fan
Guoqiang Yang
Jacqueline Kowitz
Ibrahim Akin
Xiaobo Zhou
Ibrahim El-Battrawy
author_facet Xuehui Fan
Guoqiang Yang
Jacqueline Kowitz
Ibrahim Akin
Xiaobo Zhou
Ibrahim El-Battrawy
author_sort Xuehui Fan
collection DOAJ
description Takotsubo syndrome (TTS) is identified as an acute severe ventricular systolic dysfunction, which is usually characterized by reversible and transient akinesia of walls of the ventricle in the absence of a significant obstructive coronary artery disease (CAD). Patients present with chest pain, ST-segment elevation or ischemia signs on ECG and increased troponin, similar to myocardial infarction. Currently, the known mechanisms associated with the development of TTS include elevated levels of circulating plasma catecholamines and their metabolites, coronary microvascular dysfunction, sympathetic hyperexcitability, inflammation, estrogen deficiency, spasm of the epicardial coronary vessels, genetic predisposition and thyroidal dysfunction. However, the real etiologic link remains unclear and seems to be multifactorial. Currently, the elusive pathogenesis of TTS and the lack of optimal treatment leads to the necessity of the application of experimental models or platforms for studying TTS. Excessive catecholamines can cause weakened ventricular wall motion at the apex and increased basal motion due to the apicobasal adrenoceptor gradient. The use of beta-blockers does not seem to impact the outcome of TTS patients, suggesting that signaling other than the beta-adrenoceptor-associated pathway is also involved and that the pathogenesis may be more complex than it was expected. Herein, we review the pathophysiological mechanisms related to TTS; preclinical TTS models and platforms such as animal models, human-induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) models and their usefulness for TTS studies, including exploring and improving the understanding of the pathomechanism of the disease. This might be helpful to provide novel insights on the exact pathophysiological mechanisms and may offer more information for experimental and clinical research on TTS.
first_indexed 2024-03-09T21:46:35Z
format Article
id doaj.art-ff8f4d45f63d4b8d83dd2690be491093
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T21:46:35Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-ff8f4d45f63d4b8d83dd2690be4910932023-11-23T20:17:11ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-02-01234195110.3390/ijms23041951Takotsubo Syndrome: Translational Implications and PathomechanismsXuehui Fan0Guoqiang Yang1Jacqueline Kowitz2Ibrahim Akin3Xiaobo Zhou4Ibrahim El-Battrawy5First Department of Medicine, Medical Faculty Mannheim, University Medical Centre Mannheim (UMM), University of Heidelberg, 68167 Mannheim, GermanyDepartment of Acupuncture and Rehabilitation, the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou 646000, ChinaFirst Department of Medicine, Medical Faculty Mannheim, University Medical Centre Mannheim (UMM), University of Heidelberg, 68167 Mannheim, GermanyFirst Department of Medicine, Medical Faculty Mannheim, University Medical Centre Mannheim (UMM), University of Heidelberg, 68167 Mannheim, GermanyFirst Department of Medicine, Medical Faculty Mannheim, University Medical Centre Mannheim (UMM), University of Heidelberg, 68167 Mannheim, GermanyFirst Department of Medicine, Medical Faculty Mannheim, University Medical Centre Mannheim (UMM), University of Heidelberg, 68167 Mannheim, GermanyTakotsubo syndrome (TTS) is identified as an acute severe ventricular systolic dysfunction, which is usually characterized by reversible and transient akinesia of walls of the ventricle in the absence of a significant obstructive coronary artery disease (CAD). Patients present with chest pain, ST-segment elevation or ischemia signs on ECG and increased troponin, similar to myocardial infarction. Currently, the known mechanisms associated with the development of TTS include elevated levels of circulating plasma catecholamines and their metabolites, coronary microvascular dysfunction, sympathetic hyperexcitability, inflammation, estrogen deficiency, spasm of the epicardial coronary vessels, genetic predisposition and thyroidal dysfunction. However, the real etiologic link remains unclear and seems to be multifactorial. Currently, the elusive pathogenesis of TTS and the lack of optimal treatment leads to the necessity of the application of experimental models or platforms for studying TTS. Excessive catecholamines can cause weakened ventricular wall motion at the apex and increased basal motion due to the apicobasal adrenoceptor gradient. The use of beta-blockers does not seem to impact the outcome of TTS patients, suggesting that signaling other than the beta-adrenoceptor-associated pathway is also involved and that the pathogenesis may be more complex than it was expected. Herein, we review the pathophysiological mechanisms related to TTS; preclinical TTS models and platforms such as animal models, human-induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) models and their usefulness for TTS studies, including exploring and improving the understanding of the pathomechanism of the disease. This might be helpful to provide novel insights on the exact pathophysiological mechanisms and may offer more information for experimental and clinical research on TTS.https://www.mdpi.com/1422-0067/23/4/1951Takotsubo syndromepathophysiological mechanismhuman-induced pluripotent stem cell-derived cardiomyocytescatecholaminesprecision medicine
spellingShingle Xuehui Fan
Guoqiang Yang
Jacqueline Kowitz
Ibrahim Akin
Xiaobo Zhou
Ibrahim El-Battrawy
Takotsubo Syndrome: Translational Implications and Pathomechanisms
International Journal of Molecular Sciences
Takotsubo syndrome
pathophysiological mechanism
human-induced pluripotent stem cell-derived cardiomyocytes
catecholamines
precision medicine
title Takotsubo Syndrome: Translational Implications and Pathomechanisms
title_full Takotsubo Syndrome: Translational Implications and Pathomechanisms
title_fullStr Takotsubo Syndrome: Translational Implications and Pathomechanisms
title_full_unstemmed Takotsubo Syndrome: Translational Implications and Pathomechanisms
title_short Takotsubo Syndrome: Translational Implications and Pathomechanisms
title_sort takotsubo syndrome translational implications and pathomechanisms
topic Takotsubo syndrome
pathophysiological mechanism
human-induced pluripotent stem cell-derived cardiomyocytes
catecholamines
precision medicine
url https://www.mdpi.com/1422-0067/23/4/1951
work_keys_str_mv AT xuehuifan takotsubosyndrometranslationalimplicationsandpathomechanisms
AT guoqiangyang takotsubosyndrometranslationalimplicationsandpathomechanisms
AT jacquelinekowitz takotsubosyndrometranslationalimplicationsandpathomechanisms
AT ibrahimakin takotsubosyndrometranslationalimplicationsandpathomechanisms
AT xiaobozhou takotsubosyndrometranslationalimplicationsandpathomechanisms
AT ibrahimelbattrawy takotsubosyndrometranslationalimplicationsandpathomechanisms